Has Saaron Laighold, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,114 in general payments to Saaron Laighold, MD across 21 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Saaron Laighold, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Saaron Laighold, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Saaron Laighold, MD

Cardiovascular Disease · New York, NYNPI 1801050380

Payments from drug & device makers

$2,114in general payments, 2019–2025

Across 21 payments — averaging $100.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$2K
Shockwave Medical, Inc$177
Medtronic$167
Scpharmaceuticals Inc.$57
Edwards Lifesciences$40

What the payments were for

Travel & lodging$1,51472%
Food & beverage$59928%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	14	$1,674
Shockwave Medical, Inc	1	$177
Medtronic	3	$167
Scpharmaceuticals Inc.	2	$57
Edwards Lifesciences	1	$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,114 in reported general payments places this provider in the 55th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024

$232,013

Medicare patients

953

Services billed

1,802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	26	$27,484
EntrestoSacubitril/Valsartan	13	$20,485
Nebivolol Hcl	22	$896
Rosuvastatin Calcium	41	$758
Metoprolol Succinate	37	$467
Atorvastatin Calcium	65	$361
Ezetimibe	12	$307
Losartan Potassium	28	$216
Enalapril Maleate	17	$188
Amlodipine Besylate	38	$150
Carvedilol	12	$109
ClopidogrelClopidogrel Bisulfate	12	$95
Furosemide	21	$88
Hydrochlorothiazide	14	$34

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in New York

James MinNew York$41.1M
Robert RosensonNew York$6.9M
Roxana MehranNew York$6.4M
Roger HajjarNew York$5.2M
Philippe GenereuxNew York$4.4M
Gregg StoneNew York$3.7M
Valentin FusterNew York$2.9M
Tamim NazifNew York$2.2M
Howard WeintraubNew York$1.7M
Anuradha Lala-TrindadeNew York$1.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →